Literature DB >> 4812154

Pharmacokinetics of orally administered furosemide.

M R Kelly, R E Cutler, A W Forrey, B M Kimpel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812154

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  36 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

3.  The effect of frusemide on indomethacin plasma levels.

Authors:  P M Brooks; M A Bell; P Lee; P J Rooney; W C Dick
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

4.  Pharmacokinetics of frusemide related to diuretic response [proceedings].

Authors:  R A Branch; M Homeida; D Levine; C J Roberts
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

5.  Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure.

Authors:  F Andreasen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

6.  Determinants of response to frusemide in normal subjects.

Authors:  R A Branch; C J Roberts; M Homeida; D Levine
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

7.  Pharmacokinetics of furosemide in gestosis of pregnancy.

Authors:  E Riva; P Farina; G Tognoni; S Bottino; C Orrico; G Pardi
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

8.  Pharmacokinetics/pharmacodynamics of furosemide in man: a review.

Authors:  L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

Review 9.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism.

Authors:  M G Lee; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1983-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.